1. Home >
  2. Investors >
  3. Growth Capital Firm >
  4. United States >
  5. The BroadOak Fund

The BroadOak Fund Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, The BroadOak Fund has invested in 9 companies.

The BroadOak Fund’s most common sectors for investment arelife science (80%) and healthcare services (8%) . The Firm’s most common investment types include growth capital (56%) and venture (28%). In total, The BroadOak Fund has invested in 10 US states and 3 different countries.

In the last 3 years, The BroadOak Fund has exited 2 companies. The Firm’s most common exit type is trade sale (86%). The BroadOak Fund’s largest (disclosed) exit occurred in 2014 when it sold Selah Genomics for $70M.

Subscribe to Mergr to view The BroadOak Fund’s full profile and discover more small growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity32
    • M&A Buy Activity25
    • M&A Sell Activity7
  • Total Sectors Invested 4
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 13
  • M&A Advisors 1

The BroadOak Fund

The BroadOak Fund

4800 Montgomery Lane Suite 230,
Bethesda, Maryland 20814
United States
(301) 358-2692
www.broadoak.com

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Recapitalization, Venture

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (2.8/yr) # 11 5 7 2 - - 25
Sell (0.4/yr) # 5 - - - 1 1 7
vol $70M $70M
  32

Most Recent M&A

Company Date Value Type
Halo Labs 2025-05-21 - Trade Sale
Burlingame, California · www.halolabs.com
Emvenio Research 2024-01-23 - Trade Sale
Durham, North Carolina · www.emvenio.com
Sanguine BioSciences 2023-01-09 - Venture
Woburn, Massachusetts · www.sanguinebio.com
CDI Laboratories, Inc. 2023-01-09 - Growth Capital
Mayaguez, Puerto Rico · www.cdi.bio
Emvenio Research 2022-09-28 - Growth Capital
Durham, North Carolina · www.emvenio.com
Flagship Biosciences, Inc. 2022-09-01 - Growth Capital
Broomfield, Colorado · www.flagshipbio.com
Microsize 2022-07-01 - Growth Capital
Quakertown, Pennsylvania · www.microsize.com
LabVoice, Inc. 2022-06-07 - Growth Capital
Carrboro, North Carolina · www.labvoice.ai
Biolog, Inc. 2022-05-12 - Growth Capital
Hayward, California · www.biolog.com
Rockland Immunochemicals, Inc. 2022-02-10 - Growth Capital
Limerick, Pennsylvania · www.rockland.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
PD Holdings LLC 2019-11-14 Euroapi UK Ltd. 2025-06-30 1
Saint Louis, Missouri · www.particledynamics.com Haverhill, United Kingdom
Gemini BioProducts LLC 2018-09-14 Bio-Techne - Fetal Bovine Serum (FBS) Product Rights 2024-11-25 1
West Sacramento, California · www.geminibio.com Minneapolis, Minnesota
Gemini BioProducts LLC 2018-09-14 E.I. Spectra LLC 2022-10-27 1
West Sacramento, California · www.geminibio.com Ketchum, Idaho · www.orflo.com

M&A by Sector

Sector Current # Value All-time # Value
Life Science 16 (84%) - 20 (80%) -
Healthcare Services - - 2 (8%) -
Information Technology 2 (11%) - 2 (8%) -
Test/Measurement Equipment 1 (5%) - 1 (4%) -
Total 19 - 25 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 17 (89%) - 23 (92%) -
  California 6 (32%) - 9 (36%) -
  Massachusetts 2 (11%) - 2 (8%) -
  Colorado 2 (11%) - 2 (8%) -
  Pennsylvania 2 (11%) - 2 (8%) -
  Michigan 1 (5%) - 2 (8%) -
  North Carolina 1 (5%) - 2 (8%) -
  Missouri 1 (5%) - 1 (4%) -
  Tennessee 1 (5%) - 1 (4%) -
  New Jersey 1 (5%) - 1 (4%) -
  Maryland - - 1 (4%) -
Puerto Rico 1 (5%) - 1 (4%) -
Switzerland 1 (5%) - 1 (4%) -
Total 19 - 25 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 11 (58%) - 14 (56%) -
Venture 4 (21%) - 7 (28%) -
Secondary Buyout 2 (11%) - 2 (8%) -
Buyout (LBO, MBO, MBI) 1 (5%) - 1 (4%) -
Stake Purchase 1 (5%) - 1 (4%) -
Total 19 - 25 -

Exits by Deal Type

Type Total # Value
Trade Sale 5 (71%) -
Trade Sale - Public Company 2 (29%) 70M (100%)
Total 7 $70M

Top M&A Advisors

Legal Deals
Pillsbury Winthrop Shaw Pittman
 1

Deal Values

sell # Total
< $100M 1 $70M
TOTAL $70M
Largest Selah Genomics, Inc.
$70M (2014-03-20)

M&A Connections

Deals
Acquired from
Investor(s)
8%
2 (8%)
Exited to
Strategic(s)
86%
6 (86%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Small

Specialist/Generalist

Specialist

Leadership

Matt McFarland

Managing Director

Michael Caspani

Managing Director

Bill Snider

Partner

D. Kyle Wilson

Partner

Lars Hanan

Partner

FAQ

What type of investor is The BroadOak Fund?

The BroadOak Fund is a growth capital firm.

Where is The BroadOak Fund headquartered?

The BroadOak Fund is headquartered in Bethesda, Maryland.

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal